Dilbir S. Bindra,Mandar V. Dali,Prakash V. Parab,Jatin M. Patel,Li Tao,Ravindra W. Tejwani,Nipa Vatsaraj,Yongmei Wu
申请号：
US14267984
公开号：
US09198925B2
申请日:
2014.05.02
申请国别(地区):
US
年份:
2015
代理人:
摘要：
Pharmaceutical formulations are provided which are in the form of capsules or tablets for oral use and which include a medicament dapagliflozin or its propylene glycol hydrateand a pharmaceutical acceptable carrier therefor, which formulation is designed for immediate release.
